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Abstract
Background: Preclinical research implementing fluorescence-based approaches is inevitable for drug discovery and
technology. For example, a variety of contrast agents developed for biomedical imaging are usually evaluated in cell
systems and animal models based on their conjugation to fluorescent dyes. Biodistribution studies of excised organs
are often performed by macroscopic imaging, whereas the subcellular localization though vital, is often neglected or
further validated by histological procedures. Available systems used to define the subcellular biodistribution of contrast
agents such as intravital microscopes or ex vivo histological analysis are expensive and not affordable by the majority
of researchers, or encompass tedious and time consuming steps that may modify the contrast agents and falsify the
results. Thus, affordable and more reliable approaches to study the biodistribution of contrast agents are required.
We developed fluorescent immunoliposomes specific for human fibroblast activation protein and murine endoglin,
and used macroscopic fluorescence imaging and confocal microscopy to determine their biodistribution and
subcellular localization in freshly excised mice organs at different time points post intravenous injection.
Results: Near infrared fluorescence macroscopic imaging revealed key differences in the biodistribution of the respective
immunoliposomes at different time points post injection, which correlated to the first-pass effect as well as the binding of
the probes to molecular targets within the mice organs. Thus, a higher accumulation and longer retention of the murine
endoglin immunoliposomes was seen in the lungs, liver and kidneys than the FAP specific immunoliposomes. Confocal
microscopy showed that tissue autofluorescence enables detection of organ morphology and cellular components within
freshly excised, non-processed organs, and that fluorescent probes with absorption and emission maxima beyond the
tissue autofluorescence range can be easily distinguished. Hence, the endoglin targeting immunoliposomes retained in
some organs could be detected in the vascular endothelia cells of the organs.
Conclusions: The underlying work represents a quick, effective and more reliable setup to validate the macroscopic and
subcellular biodistribution of contrast agents in freshly excised animal organs. The approach will be highly beneficial to
many researchers involved in nanodrug design or in fluorescence-based studies on disease pathogenesis.
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Background
In the majority of diseases, molecular alterations precede
detectable pathological changes by various durations,
which can range from weeks to years. Such molecular
events and changes help in prediction, diagnosis and
therapy of diseases. Therefore, molecular imaging, which
is defined as the non-invasive real time visualization of
biochemical events at the cellular and molecular level
within living cells, tissues and/or whole organisms [1–3]
holds an influential position in medicine. Thus, molecu-
lar imaging has been implemented in a wide field of bio-
medical research on drug discovery [4, 5], disease
pathogenesis and is of vital importance in nuclear medi-
cine, amongst others [6]. In preclinical research, molecu-
lar imaging is applied to study disease pathogenesis,
drug efficacy and diagnostic properties of contrast agents
and molecular tracers. Such researches often rely on
fluorescent agents that can be attached to drugs, tracers
and other non-fluorescent contrast agents in order to
non-invasively monitor their properties and biodistribu-
tion by fluorescence detection [5]. For instance fluores-
cence imaging is exploited to characterize contrast
agents aimed for applications in positron emission tom-
ography (PET) [7] or magnetic resonance imaging (MRI)
[8]. Due to the limited penetration depth of light, fluor-
escence imaging is more feasible in diagnostic imaging
of superficial diseases such as rheumatoid arthritis [9],
skin, head and neck and breast cancers and for endo-
scopic imaging of colon cancers as well as intraoperative
setups where the surgeon directly visualizes diseased
tissues in real time [10]. Hence, fluorescence imaging is
more widely applied in drug development and studies on
disease pathogenesis, and as well in theranostic ap-
proaches, whereby the dyes which serve as therapeutics
are encapsulated in the core of lipidic nanoparticles, as
was recently demonstrated by Anikeeva et al. [11]. In
such preclinical studies, different criteria are applied to
evaluate the suitability of molecular contrast agents or
targeted therapeutic drugs for future applications in
humans. Besides the stability and specificity of the
molecular probes, their biocompatibility and suitable
clearance is vital. Therefore, many preclinical animal
trials include biodistribution experiments, whereby the
fluorescence signals of the drugs or contrast agents
within excised organs are monitored ex vivo. In this
respect, several reports demonstrate macroscopic evi-
dence for the biodistribution of fluorescent probes and
contrast agents in organs involved in probe degradation
and elimination, such as the liver, kidneys and gastro in-
testinal tract [12]. However, few reports pinpoint the cells
and compartments involved in the accumulation of these
probes within the organs. Considering that the subcellular
localization or longer retention of drugs and contrast
agents in some organs may pose adverse side effects [13,
14], it is relevant to include different exposure time points
and also to pinpoint the subcells involved in the biodistri-
bution of the said contrast agents or drugs. Model systems
for example intravital microscopes permit kinetic studies
of probes and enable visualization of their subcellular
localization in the organs in real time [15]. However, most
instruments which permit these studies are bulky, expen-
sive and demand expertise in handling. Furthermore, the
studies concentrate on a single organ or area at a time,
whereas a lot of information in the other organs is not ad-
dressed. Ex vivo histological analyses can detect the sub-
cellular localization of probes within organs. This however,
involves microscopic imaging of tissue sections and de-
mands conservation and processing of the tissues. The
steps involved are tedious, time consuming and also rela-
tively expensive. Furthermore, conservation and process-
ing can lead to loss, or modification of the contrast agents
being addressed, resulting in unreliable or contradictory
results in some cases.
We therefore looked for alternative cost-effective setups
to effectively image and correlate the macroscopic distri-
bution and subcellular localization of fluorescent probes
in freshly isolated organs. Using a simple confocal micros-
copy setup to image freshly excised organs, we could dem-
onstrate the feasibility of determining the subcellular
localization of contrast agents and correlate this with re-
sults acquired by macroscopic imaging. Hereby, tissue au-
tofluorescence which originate from water, hemoglobin,
flavins collagens and many other pigments was exploited
in defining several organs / tissue structures as demon-
strated earlier [16]. The tissue fluorophores absorb and
emit light at different wavelengths which lie beyond the
near-infrared (NIR) optical window (650 nm - 900 nm)
[17]. Hence, fluorescent probes which absorb and emit at
these NIR wavelengths can be conveniently detected. A
bulk of preclinical and clinical applications therefore
utilizes NIR fluorescent (NIRF) dyes with absorption and
emission wavelengths between 650 nm and 900 nm as the
source of contrast [18–20]. In the underlying research, the
biodistribution and subcellular localization of two liposo-
mal formulations were elucidated. The liposomes were
encapsulated with a high concentration of the NIRF dye,
DY-676-COOH (excitation /emission: 674 nm /699 nm)
and conjugated to single chain antibody fragments (scFv)
directed to either fibroblast activation protein (FAP) which
is overexpressed on tumor associated fibroblasts of 90% of
tumors but not healthy tissues [21], or to endoglin, which
is overexpressed on some tumor cells and the majority of
tumor neovasculature [22]. We demonstrate that confocal
microscopic imaging of freshly excised organs can detect
the subcellular localization of fluorescent probes, which
could be correlated to the observations made by macro-
scopic imaging. Hence, characteristic differences were
detected in the distribution and subcellular localization of
Tansi et al. BMC Biotechnology  (2017) 17:8 Page 2 of 11
the liposome formulations over time post injection. The
results expose the relevance of combining microscopic
imaging with macroscopic imaging in order to make reli-
able conclusions about the biodistribution and related
clearance of molecular optical imaging agents. Taken to-
gether, the approach is fast, easy to accomplish and repre-
sents a reliable and cost effective exploitation of the tissue
autofluorescence to substantiate the subcellular localization
and biodistribution of imaging probes and fluorescent
therapeutics.
Methods
Preparation and physicochemical characterization of
immunoliposomes
A detailed description of the preparation and physical
characterization of the ligand targeted immunoliposomes
with high concentrations of the NIRF dye, DY-676-COOH
(excitation / emission: 674 nm /699 nm) in the aqueous
interior and the green fluorescent phospholipid NBD-
DOPE (excitation / emission: 480 nm /530 nm) on the
lipid bilayer was reported earlier [23–25]. The liposomes
were fused with human FAP’scFv conjugated to micelles
to get FAP-IL or murine endoglin scFv conjugated
micelles to get mEnd-IL. Human and murine FAP share a
high amino acid sequence homology and hence antibody
cross reactivity [26], whereas murine and human endoglin
share no homology or antibody cross reactivity.
Uptake of liposomal probes and imaging
To prove the in vitro selectivity of the respective immuno-
liposomes to human FAP (FAP-IL) or to murine endoglin
protein (mEnd-IL), human fibrosarcoma cells stably
expressing FAP (HT1080-hFAP) and murine melanoma
(B16F10-mEnd) endogenously expressing low levels of
endoglin and further stably cloned with a murine endoglin
gene were used. 30,000 cells of each cell line were seeded
and grown for 16 h on poly-L-lysine-coated 8-well culture
slides (BD Biosciences), then treated with 200 nmol (final
lipid) of the liposomes for 6 h at 37 °C. The non-targeted
quenched liposome, (LipQ) and the free DY-676-COOH
(at a concentration equivalent to the dye content of FAP-
IL) were used as controls. Likewise, the murine macro-
phage cell line J774A.1 was seeded at 50,000 cells / well
and treated with the respective probes to substantiate their
uptake by phagocytosis. Cell harvest, nuclei stain with
Hoechst-33258 (Applichem), mounting with Permafluor
and subsequent confocal microscopy was done as reported
in detail earlier [23]. Whereas the nuclei were visualized
with a 405 nm laser diode and a 420-480 nm band pass
filter, NBD-DOPE was detected similar to GFP by exciting
at 488 nm and capturing the fluorescence at 530 nm. A
633 nm Argon laser was used to excite DY-676-COOH
and the emission captured with a 650 nm long pass filter.
A 63x magnification was applied for all images.
Animals
All animal studies were approved by the regional animal
committee and conformed to international guidelines on
the ethical use of animals. Female athymic nude mice
(Hsd:Athymic Nude-Foxn1nu nu/nu; Harlan Laborator-
ies) ranging between 10-18 weeks were housed under
standard conditions with ad libitum mouse chow and
water. One week before probe injection and imaging, the
mice were given a low pheophorbide diet (C1039,
Altromin) in order to reduce tissue autofluorescence.
Determination of the biodistribution of liposomes by
fluorescence imaging
A comparison of macroscopic and microscopic imaging
of freshly dissected organs was performed according to
the following workflow (Fig. 1).
Macroscopic NIRF imaging and determination of the
biodistribution of FAP-IL and mEnd-IL
The mice were anesthetized with 2% isoflurane and the
respective probes (20 μmol per kg weight (final lipids) of
FAP-IL or mEnd-IL diluted in PBS to 150 μl final
volume) were administered by tail vein injection. The
Fig. 1 Scheme of the steps involved in determining the biodistribution of FAP-IL and mEnd-IL in mice
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animals were sacrificed at different time points post in-
jection (p.i.) and the organs immediately excised and im-
aged. Macroscopic images of the excised organs were
acquired with the MaestroTM in vivo fluorescence im-
aging system (Cri-InTAS, Woburn USA) with filters for
the excitation range 615-665 nm and acquiring emission
with a cut-in filter (>700 nm). The background auto-
fluorescence were unmixed and determination of the
semi-quantitative levels of the fluorescence intensities
of respective organs were done with the Maestro soft-
ware by assigning regions of interest (ROIs) on each
of the intensity scaled (for exposure time, camera
gain, binning and bit depth) organs as described else-
where [23]. Fluorescence intensities of the ROIs were
derived as average signal (scaled counts/s) and are
comparable among each other.
Euthanasia
Animals were anesthetized with 2% isoflurane till they
no longer reacted to touch, and then sacrificed with car-
bon dioxide till breathing stopped completely.
Confocal microscopy of freshly isolated organs
Immediately after excision, the organs were quickly
rinsed in sterile PBS and placed on the glass platform of
an LSM780 confocal microscope (Zeiss, Jena Germany).
Otherwise, a small piece of the freshly excised organs
was smoothly cut with a sharp scalpel and placed with
the smooth surface lying on a glass coverslip of a
Lab-Tek™ 4-well borosilicate cover-glass system (Thermo-
Scientific, Germany) and imaged on an LSM510Meta
confocal laser scanning microscope (Zeiss, Jena Germany).
To avoid dehydration during tile scanning microscopy, a
drop of PBS was placed in one empty well (Fig. 1) and
the chamber slides covered all through microscopy
(LSM510Meta). In this constellation, whereby the organs
are imaged without processing, the strong tissue auto-
fluorescence (blue to green fluorescence) of the fresh or-
gans permits detail visualization of the organ structures,
whereas the injected contrast agents with fluorescence ab-
sorption and emission maxima beyond the autofluores-
cence range (e.g. liposomal DY-676-COOH: abs/em. 674
/699 nm) can be clearly distinguished. Images were
acquired at similar excitation and emission settings like in
cellular uptake experiments. The whole cells were visual-
ized based on autofluorescence by excitation in the blue
region with a 405 nm laser diode and a 420-480 nm band-
pass filter. The fluorescence of minimal green autofluores-
cent tissue components and also liposomal NBD-DOPE
was detected with the GFP filter at 530 nm after excitation
at 488 nm. DY-676-COOH was excited with a 633 nm
argon laser and emission captured with a 650 nm longpass
filter. Images were acquired at a 20x magnification.
Statistical data
The student’s t-test was used, if not otherwise stated, to
deduce the level of significance, when normality and
equal variance tests were passed. If not, Mann-Whitney-
Rank sum test was applied. All experiments were done
at least twice. For animal trials, four or more animals /
group were used. Differences resulting in P < 0.05 were
considered significant.
Results
Properties of the immunoliposomes
The immunoliposomes contained high concentrations of
the fluorescence-quenched NIRF dye, DY-676-COOH
encapsulated in their aqueous interior and the non-
quenched green fluorescent NBD-DOPE on the lipid
bilayer. Hence, the quenched liposomes termed LipQ
possessed dual fluorescence for imaging in the green
and also near-infrared wavelength range. The green
fluorescent phospholipid enables detection of the intact
liposomes prior to their degradation and activation of
the DY-676-COOH. For selective targeting, single chain
antibody fragments directed to the human FAP or mur-
ine endoglin proteins were conjugated to their surface
by the post-insertion method (Fig. 2a) and the probes
termed FAP-IL and mEnd-IL, respectively. Mouse and
murine FAP share high amino acid sequence homology
and subsequent antibody cross-reactivity, whereas mur-
ine endoglin antibodies do not cross react with human
endoglin and vice versa. Consequently, fibrosarcoma
cells expressing endogenous human endoglin, and stably
transformed to additionally express human FAP select-
ively took up FAP-IL, but not the mEnd-IL, control
LipQ nor the free DY-676-COOH (Fig. 2b, HT1080-
hFAP). Likewise, the mouse melanoma cell line with
high levels of stably transformed murine endoglin select-
ively took up mEnd-IL, but not FAP-IL, LipQ nor the
free DY-676-COOH (Fig. 2b, B16F10-mEnd), which sub-
stantiates the target selectivity of the respective immu-
noliposomes. In the endoglin expressing cell line in
particular, binding of mEnd-IL at 4 °C reveals only the
non-quenched green fluorescent phospholipid embedded
in the liposomal bilayer (Fig. 2, B16F10-mEnd, 4 °C),
underscoring the importance of the phospholipid in
tracking the intact quenched liposomes prior to their
activation. Furthermore, all the probes could be taken
up by phagocytosis, as can be seen in the murine macro-
phage cell line J774A.1 (Fig. 2c).
Macroscopic NIRF imaging show fluorescence
distributions indicative of first pass effect, retention and
also washout at different time points post injection
We verified whether the first pass effect of fluorescent
probes can be effectively imaged and whether the data
acquired would provide indications of the probes’ later
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degradation and clearance from the system. Also, the se-
lectivity of the immunoliposomes for their target pro-
teins was investigated. Provided there is overexpression
of FAP or endoglin proteins in any mice organs, selective
accumulation and retention of the respective probes will
take place, owing to the ability of both probes to bind
the murine targets. The probes were therefore intraven-
ously applied in nude mice and the organs isolated at
1 h, 6 h and 24 h post injection (p.i.) and subjected to
NIRF imaging.
At 1 h p.i., high fluorescence signals were detected in
the lungs, liver, kidneys, gall bladder and duodenum
(Fig. 3). This represents probe distribution resulting pre-
dominantly from the first pass effect. After intravenous
injection, the probes rapidly circulate in blood and are
retained or visible in organs with high levels of blood
flow (e.g. lungs) or high levels of blood flow as well as
processing (e.g. liver). Due to initial rapid degradation by
liver kuppfer cells and secretion to the bile, a high fluor-
escence is detected in the gall bladder at this time point
(1 h p.i.). From the gall bladder the probes are further
released to the duodenum, as seen in the high fluores-
cence of the duodenum. Evident for a partial elimination
of the probe via the kidney, a minimal fluorescence sig-
nal is seen in the kidneys at 1 h p.i. (Fig. 3). Comparing
FAP-IL and mEnd-IL, some differences can be seen in
the fluorescence intensity of the organs at various time
points. While the FAP-IL causes lung fluorescence only
as a “first-pass” effect seen at 1 h p.i., the mEnd-IL accu-
mulates and is retained in the lungs for longer durations
(Fig. 3, mEndl-IL 6 h). Likewise, FAP-IL in the liver is
rapidly degraded and eliminated with time, whereas a
lower amount is retained in the kidneys and persists till
24 h. In the gastro intestinal tract (GIT), FAP-IL
fluorescence is seen to move over time, from the duode-
num towards jejunum, ileum and caecum from where it
is excreted through the colorectum in feces.
Opposed to FAP-IL, the mEnd-IL signals increases in
the liver and GIT till 24 h p. i. The liver seems incapable
of rapidly degrading the mEnd-IL, hence very high liver
fluorescence is seen at 24 h. Furthermore, the gall bladder
from mice which received mEnd-IL show increasing fluor-
escence signals with time, and relatively high levels at 24 h
p.i. These observations strongly suggest that accumulation
of mEnd-IL in the liver and other organs such as lungs are
not a result of the first pass effect alone, but rather based
on molecular interaction with murine endoglin protein
which is possibly expressed in these organs at high levels.
The differences observed between the FAP-IL and the
mEnd-IL which only differ in the targeting moieties used,
therefore raised many questions. It was thus vital to
pinpoint the subcellular factors responsible for the differ-
ent biodistribution and retention.
Semi-quantitative evaluations revealed fluorescence
intensities of organs which correlated well with the
observations made earlier (Fig. 3), and substantiated the
distribution and subsequent elimination of the probes
with increase in duration post i. v. injection. Thus, the
highest fluorescence levels were deduced 6 h p.i. (Fig. 4).
Confocal microscopy of freshly resected lungs, liver and
kidneys pinpoint the subcellular components involved in
probe elimination or retention
Lung tissues of mice isolated 1 h or 6 h p.i. of mEnd-IL
revealed high fluorescence signals of the endothelia cells
(Fig. 5a). Likewise, the liver sinusoidal cells showed
strong fluorescence of the mEnd-IL at these time points
(Fig. 5b, white arrows), whereas very few kuppfer cells
Fig. 2 Schematic presentation of the properties of the immunoliposomes used. a Preparation of immunoliposomes with high concentration of
encapsulated DY676-COOH, and post insertion of micelles bearing human FAP and murine endoglin scFv. b Target selectivity of FAP-IL, mEnd-IL,
non-targeted quenched liposome, LipQ and the free DY-676-COOH (at a concentration equivalent to the DY-676-COOH content in FAP-IL) after
incubation with target expressing cells at 37 °C or 4 °C for 6 h. c Validation of the phagocytic uptake of liposomal probes by murine macrophages
J774A.1 after 6 h incubation at 37 °C
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were detected with the mEnd-IL fluorescence (Fig. 5b,
yellow arrows). Furthermore, the strong mEnd-IL based
fluorescence in the endothelia cells only reduced grad-
ually with time. Thus, at 24 h p.i. of mEnd-IL, liver
endothelia cells still showed high fluorescence signals.
Opposed to mEnd-IL, the liver excised from mice which
received FAP-IL revealed liposomal fluorescence pre-
dominantly in the kuppfer cells (Fig. 5b, yellow arrows)
and the bile canaliculi (Fig. 5b, pink arrows). This was
high at 1 h and 6 h p.i., but rarely detectable after 24 h.
Also, the lungs showed mild liposomal fluorescence 1 h
post application of FAP-IL, but revealed no further sig-
nals at 6 h and 24 h post injection, indicating that their
accumulation in lungs is due to the first-pass effect.
Interestingly, the kidneys revealed comparable abilities
to retain both the mEnd-IL and the FAP-IL fluorescent
components for longer durations after injection. How-
ever, the localization of the characteristic DY676-COOH
fluorescence in the kidneys over time exposed indica-
tions for its mode of elimination. Thus, microscopic
images of kidney cross sections showed fluorescence
localized in the cortex at 1 h and 6 h p. i. of both probes
(Fig. 6a). Additionally, the mEnd-IL based fluorescence
was seen in the blood vessels of the kidneys, 1 h after
injection (Fig. 6a, mEnd-IL white arrows). At 24 h post
application, this fluorescence was predominantly local-
ized in the tubules of the kidney pyramids and pelvis, ir-
respective of the probe applied.
Though organs like the spleen, heart and brain retained
little or none of the probes injected, their morphological
detection based on autofluorescence was possible. In the
brain, the arteries and veins showed different levels of au-
tofluorescence (Fig. 6b). Compared to FAP-IL, the mEnd-
IL seems to partially bind the brain endothelia cells. This
was evident in a minor fluorescence of the cells lining the
blood vessels in the brain (Fig. 6b, mEnd-IL pink arrow).
Opposed to this, FAP-IL based fluorescence was not seen
in the brain. Compared to the brain, there was no fluores-
cence of the probes detected in the heart, whereas the
spleen revealed distorted fluorescence distribution of
especially the mEnd-IL (not shown).
Influence of post mortem staining of nuclei in fresh
organs directly after isolation
Microscopic imaging: heart, lungs, spleen, liver, kidneys
and tumors
We also verified if detection of internalized probes will
be possible after rapid nuclei stain of the fresh organs.
Fig. 3 Representative intensity scaled NIRF images of mice organs showing distribution of liposomal fluorescence at different time points post
injection. At 1 h post injection first pass distribution in lungs, kidneys, liver, gall bladder and preliminary release to the duodenum are seen for
both FAP-IL and mEnd-IL. At 6 h post injection, FAP-IL is washed out from the lungs and partially from the liver and secreted to the gall bladder,
but retained in the kidneys. Release from the gall bladder to the duodenum and excretion via the GIT is evident in the fluorescence movement
from duodenum to the jejunum, ileum and colorectum with time. The mEnd-IL is retained in the lungs, kidneys and liver and only gradually
eliminated via the GIT with time
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We observed that imaging based on the tissue autofluo-
rescence was superior to Hoechst-33258-stained fresh
tissues. This was basically because the morphological
features of the tissues and organs were lost, due to a
strong unspecific stain of several tissue components by
the Hoechst-33258 solution (results not shown). This
observation further underlines the benefits of exploiting
the tissue autofluorescence in microscopic determin-
ation of the biodistribution of contrast agents.
Discussion
In most preclinical biodistribution studies, researchers
generally assume that the accumulation of drugs or
fluorescent probes in the liver or kidneys portray their
degradation and excretion via the hepatobiliary or urin-
ary routes [12, 23]. In such studies organs are analyzed
at a single time point (e.g. 6 h or 8 h) post probe
application. However, vital information on the subcellu-
lar distribution and possible damage to the organs due
to long retentions remain undocumented in such stud-
ies. The underlying results demonstrates the importance
of monitoring the biodistribution at many time points in
order to make reliable conclusions on probe distribution,
retention and their later elimination from the system. A
longer retention of some contrast agents in several
organs could result in adverse side effects [13, 14, 27]
depending on the subcellular localization, since different
tissue cells react differently to different agents. Thus, it
is important to know which subcellular factors are
responsible for the retention of probes in different or-
gans, for example excretory organs such as the liver,
kidney and also sensitive organs not involved in biodeg-
radation and excretion, such as the lungs, brain and
heart. A longer retention in the liver could be due to a
slower degradation, or unwanted affinity of the probes
to molecular structures in the organs as seen with the
mEnd-IL. Based on the contrast agent or therapeutic
drug in question, this may cause adverse side effects. For
example prolonged retention in the liver may implicate
adverse effects of the probes on the kuppfer cells, or
sinusoids of the liver or on the secretion to the bile.
Likewise, longer retentions in the kidney due to formation
of unfilterable aggregates may pose damages with time. A
major reason why many researches do not include
Fig. 4 Semi-quantitative levels of fluorescence intensities of organs at the given time points (a 1 h, b 6 h and c 24 h) post injection of PBS, FAP-IL or
mEnd-IL. Each bar depicts the mean fluorescence of the respective organs per time point. n = 4 ± SD for the 6 h and 24 h groups and n = 3 ± SD for
the 1 h group
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microscopic validation of the subcellular localization of
probes is lack of suitable equipment. Thus, we verified if
the use of simple and easily accessible microscopy setups
could enable this.
Using macroscopic NIRF imaging, we could determine
the biodistribution of targeted immunoliposomes based
on the first-pass effect post injection and also their
retention based on molecular targeting to different tar-
get cells. Interesting differences were seen between the
FAP-IL and the mEnd-IL. Whereas, the FAP-IL distrib-
uted predominantly based on the first pass effect and
subsequent elimination, the mEnd-IL revealed longer
durations of retention in vital organs such as the lungs,
liver and kidneys. The first-pass effect of FAP-IL was es-
pecially characterized by fluorescence of lungs which
disappeared before 6 h post injection. This was coupled
with a preliminary fluorescence of the gall bladder, liver,
duodenum and kidneys at 1 h p.i., which increased in
these organs after 6 h, and subsequently decreased 24 h
after injection. Furthermore, a gradual movement of the
fluorescence from the duodenum towards the jejunum,
ileum and colorectum with increasing time post applica-
tion indicated probe elimination via feces. The relatively
high fluorescence signals of both immunoliposomes seen
in the stomach could not directly be explained. We
postulated previously [25] that this fluorescence may
Fig. 5 Subcellular distribution of FAP-IL and mEnd-IL fluorescence in freshly resected lungs and liver. a Lungs, showing the liposomal green/red
fluorescence particularly 6 h post injection of mEnd-IL. b Liver, showing the liposomal green/red fluorescence of FAP-IL in kupffer cells (yellow arrows)
and bile canaliculi (pink arrows) and the mEnd-IL fluorescence predominantly in the liver sinusoidal cells (white arrows). At 6 h and 24 h post injection
the location of the liposomal fluorescence is the same, but a predominant red fluorescence of the released DY-676-COOH is seen
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result from pancreatic and partial bile release of probes
into the stomach like in humans, or due to reflux from
the duodenum. This is supported by the fact that the
fluorescence increases with time post injection and is
very high even at time points when there is no fluores-
cence in the duodenum. Although the liposomes are not
pH sensitive, and microscopic images demonstrate the
secretion of the liposomal DY-676-COOH and NBD-
DOPE in the bile canaliculi of the liver, which implies
their eventual delivery to the gall bladder and stomach
as individual components and not intact liposomes, the
low pH of the stomach could possibly influence the DY-
676-COOH and play a role in the high NIRF detected
here. Contrary to FAP-IL, the combination of first-pass
effect and molecular targeting by the mEnd-IL caused
longer retention of the probe in many organs including
the lungs, liver and kidneys as seen by macroscopic
imaging. This retention could be detected based on the
different time points considered and exposes the relevance
of this consideration in biodistribution studies. Besides
considering several time points, it is also important to
pinpoint the sub cells responsible for the probe retention.
We therefore implemented a simple fresh organ micros-
copy setup to validate this. Although tissue autofluores-
cence interferes with in vivo fluorescence imaging, it has
been exploited in defining several organs / tissue struc-
tures and to distinguish pathological changes in diseased
tissues [16]. Thus, cellular and tissue autofluorescence
originating from mitochondria, lysozymes, lipo-pigments
and pyridinic (NADPH), flavin coenzymes, collagen,
elastin, hemoglobin and melanin are successfully exploited
for diverse applications such as in endoscopic imaging
[28] and intravital microscopy [29, 30]. These tissue
fluorophores absorb and emit light at different wave-
lengths which lie beyond the near-infrared optical window
(650 nm - 900 nm) [17]. Consequently, the fluorescence
of the liposomal encapsulated NIRF dye, DY-676-COOH
(abs/em max. 674 /699 nm) could be easily distinguished
from tissue autofluorescence of freshly excised organs.
Whereas the lungs of FAP-IL treated mice revealed no de-
tectable fluorescence signals, the liver and kidneys re-
vealed distinct liposomal fluorescence at the different time
points investigated. The kidneys showed mild fluorescence
of the blood vessels and tubules of the cortex at 1 h p.i.
and predominantly in the pyramids and pelvis with in-
creased duration post injection. This indicates a partial,
but gradual elimination of the probes in urine [25]. It was
shown previously that DY-676 is highly hydrophobic and
hence preferentially eliminated by the hepatobiliary route
[12]. Consistent with this, the FAP-IL based fluorescence
was located predominantly in kuppfer cells of the liver at
all the investigated time points. The liver kuppfer cells are
responsible for the host defense. When toxic or foreign
substances are recognized by the system they opsonize the
foreign substances, making them recognizable by macro-
phages which engulf them in the blood and migrate to the
liver. In the liver the macrophages (both infiltrating and
resident) are called kuppfer cells [31]. While in the liver
they degrade the foreign substances which can then be se-
creted to the bile for elimination to the duodenum as was
evident in the macroscopic images. However, the probes
can also reach the liver directly through blood circulation.
This is achieved by the first pass effect as well as repeated
circulation of long circulating probes such as the immu-
noliposomes used herein. Notably, the FAP-IL undergoes
only circulation, phagocytic uptake and degradation due
Fig. 6 Subcellular distribution of FAP-IL and mEnd-IL fluorescence in freshly isolated kidneys (a) and brain (b). The liposomal signals are seen as
green/red fluorescence in the kidney cells (FAP-IL) or blood vessels (mEnd-IL) at 1 h post injection (white arrows). At 6 h and 24 h p.i., a predominant
red fluorescence of the released DY-676-COOH is seen in the tubules of the kidney pyramids (yellow arrows). b Opposed to FAP-IL which shows no
signals in the brain, mEnd-IL accumulates in cells lying close to the brain blood vessels (pink arrows), whereas no signals are seen in the arteries
(orange arrows)
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to the lack of targets in the mice used, since FAP is exclu-
sively expressed in diseased but not healthy tissues [21].
Opposed to FAP-IL, the mEnd-IL was detected in the
lung, brain, kidney and liver endothelia cells. The fact
that mEnd-IL localized in these endothelial cells sub-
stantiates the stability of the PEGylated liposomes in the
blood circulation and their selectivity for murine endo-
glin. Hence, they enter the liver and other organs as in-
tact vesicles which then specifically bind and are taken
up and degraded by the respective endothelial cells, re-
leasing the encapsulated DY-676-COOH. The free DY-
676-COOH can be taken up by phagocytic cells but not
by other cell types (see also Fig. 2), and is more rapidly
eliminated than the long circulating liposomes in vivo
[24]. Thus, the predominant green fluorescence and co-
localization of the green and red fluorescence of liposo-
mal NBD-DOPE and DY-676-COOH in organs such as
liver and kidneys at 1 h p.i. for example, is indicative of
the accumulation of intact liposomes, which eventually
get degraded to release / activate the encapsulated DY-
676-COOH in these organs (see Fig. 5b and Fig. 6a).
This highlights the role of the non-quenched green
fluorescent phospholipid, NBD-DOPE in tracking the in-
tact versus degraded liposomes as was demonstrated in
time course experiments earlier [24, 25] and also here-
with (Fig. 2b, 4 °C). Based on earlier cytoxicity studies
[19], it is known that the encapsulated DY-676-COOH is
not cytotoxic. Considering that a cytotoxic substance
used in its place could exert damages on the liver, lungs
and brain endothelial cells upon long retentions, our
results expose the importance of including microscopy
as part of a biodistribution study. Furthermore, our
results show that this is possible on freshly resected tissue.
Thus, exploiting the tissue autofluorescence helps detect
morphological changes that may result from adverse
effects of the applied probes. This is especially feasible
when characterizing the biodistribution of contrast agents
coupled to a fluorophore with absorption and emission
maxima in the near infrared optical window. Neverthe-
less, fluorescent dyes with lower wavelengths can be
detected if their concentrations are much higher than
that of the tissue autofluorescence. In our images for
example, we could detect the green fluorescent
phospholipid, NBD-DOPE (abs / em.: 480 nm / 530 nm),
due to its high concentration and resulting strong signals
which outshined the background autofluorescence. We
therefore strongly recommend using this method when
analyzing fluorescent probes with spectroscopic properties
lying beyond the tissue autofluorescence range (650-
900 nm). However, if the concentration of a probe is
very high it could be detected similar to the NBD-
DOPE used herein. In this case a comparison with a
second dye would be of advantage, to avoid false
interpretation.
Conclusion
We demonstrate a simple, cost effective approach to
suitably determine the subcellular distribution of con-
trast agents and drugs in freshly isolated organs by con-
focal microscopy. The result sheds light on the cellular
subsets involved in the biodistribution of contrast agents
and suggests the consideration of several time points in
biodistribution studies. Implementing the approach will
improve preclinical characterization of contrast agents
or theranostic agents designed for future clinical applica-
tions. Furthermore, the approach holds potentials to be
expanded to clinical units where fluorescence based in-
traoperative setups and biochemical / histological evalu-
ation of excised tissues are microscopically characterized
immediately. We are therefore convinced that many re-
searchers and clinical units will benefit from the simple
approach demonstrated herein.
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